Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 19;6(2):e03431.
doi: 10.1016/j.heliyon.2020.e03431. eCollection 2020 Feb.

Gallic acid and MiADMSA reversed arsenic induced oxidative/nitrosative damage in rat red blood cells

Archna Panghal  1 , Kshirod Bihari Sathua  1 , S J S Flora  1
Affiliations

Gallic acid and MiADMSA reversed arsenic induced oxidative/nitrosative damage in rat red blood cells

Archna Panghal et al. Heliyon. .

Abstract

Arsenic (As) is naturally occurring toxic metalloid which is considered as a serious environmental and health concern. Red blood cells are the prime target for any toxicants as their population is higher in systemic circulation. High prevalence of anaemia too has been reported from arsenic contaminated area, suggesting possible linkage between arsenic and the damaging effects on RBCs. The exact mechanism for these effects is still not clear, however, oxidative/nitrosative stress might be one of the causative factors to play a key role. The present study was planned to evaluate the protective effects of a metal chelator, MiADMSA either alone or in combination with a natural antioxidant (gallic acid) for the reversal of arsenic induced oxidative damage in red blood cells. We collected rat RBCs and cultured them in appropriate medium. They were incubated with MiADMSA and gallic acid and then treated with sodium arsenite at 37 °C. Hemolysates were prepared and assayed for various biochemical parameters such as oxidative/nitrosative variables, osmotic fragility, acetylcholinesterase activity, and cellular metal accumulation. We found there was reversibility of oxidative/nitrosative stress variables, elevated cellular antioxidant power, and decreased osmotic fragility of red blood cells both in MiADMSA alone as well as in combination with gallic acid treated group compared with arsenic treated group. In conclusion, MiADMSA efficiently participated in the reversal of arsenic induced oxidative/nitrosative damage in red blood cells where as Gallic acid improved its reversal when given in combination with MiADMSA.

Keywords: Antioxidant; Behavioral neuroscience; Developmental biology; Flavonoid; Gallic acid; MiADMSA; Nervous system; Neurotoxicology; Oxidative stress; Oxidative/nitrosative stress; Pathophysiology; Photochemical; Reactive oxygen species; Red blood cells; Sodium arsenite; Toxicology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Concentration of arsenic in whole blood at different time interval after single dose oral administration in male Wistar rats.
Figure 2
Figure 2
Concentration of arsenic in RBCs of various groups. All the values are expressed as mean ± SEM (n = 3), ****P < 0.0001 vs control, #P < 0.05, ##P < 0.01 vs arsenic and $$$$P < 0.0001 vs As + MiADMSA. [GA = gallic acid, MiADMSA = monoisoamyl DMSA, As = arsenic].
Figure 3
Figure 3
Effect of arsenic exposure on osmotic fragility. All the values are expressed as mean ± SEM (n = 3), ****P < 0.0001 vs. Control and ####P < 0.0001 vs. Arsenic and $$$$P < 0.0001 vs. Arsenic + MiADMSA.
Figure 4
Figure 4
A) Effect of arsenic exposure and protective therapies on ROS level B) Effect of arsenic exposure and protective therapies on antioxidant power. All the values are expressed as mean ± SEM (n = 3), **P < 0.01, ****P < 0.0001 vs. Control and #P < 0.05, ##P < 0.01, ####P < 0.0001 vs. Arsenic $$P < 0.01 vs. Arsenic + MiADMSA.
Figure 5
Figure 5
A) Effect of arsenic exposure and protective therapies on MDA level B) Effect of arsenic exposure and protective therapies on reduced GSH level. C) Effect of arsenic exposure and protective therapies on catalase activity. D) Effect of arsenic exposure and protective therapies on SOD activity. E) Effect of arsenic exposure and protective therapies on nitrite level. All the values are expressed as mean ± SEM (n = 3), ****P < 0.0001 vs. Control and #P < 0.05, ##P < 0.01, ####P < 0.0001 vs. Arsenic and $$$P < 0.0001 vs. Arsenic + MiADMSA.
Figure 6
Figure 6
Effect of arsenic exposure and protective therapies on AChE activity. All the values are expressed as mean ± SEM (n = 3), ***P < 0.001, vs. Control and ####P < 0.0001 vs. Arsenic and $$$$P < 0.0001 vs. Arsenic + MiADMSA.
Figure 7
Figure 7
Inverted microscopic images of RBCs. (A) Untreated control cells. RBCs treated with (B) MiADMSA alone (C) Gallic acid alone and (D) SA alone (E) combination of SA and MiADMSA (F) combination of Gallic acid and MiADMSA (G) combination of SA, MiADMSA and Gallic acid. Morphological view of all group have taken on 100X magnification. Contrast and brightness was adjusted by Microsoft picture manager 2007.
See this image and copyright information in PMC

References

    1. Flora S.J.S. Arsenic-induced oxidative stress and its reversibility. Free Radic. Biol. Med. 2011;51(2):257–281. - PubMed
    1. Flora S.J.S., Flora G., Saxena G. Arsenicals: toxicity, their use as chemical warfare agents and possible remedial measures. In: Gupta R.C., editor. Handbook of the Toxicology of Chemical Warfare Agents. Academic Press; San Diego: 2009. pp. 109–133.
    1. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005;12(10):1161–1208. - PubMed
    1. Chowdhury U.K., Biswas B.K. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ. Health Perspect. 2000;108(5):393–397. - PMC - PubMed
    1. Mazumder D.N.G., Haque R., Ghosh N., De B.K., Santra A., Chakraborty D., Smith A.H. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int. J. Epidemiol. 1998;27:871–877. - PubMed